Antibody may improve plaque psoriasis

Article

A fully human monoclonal antibody that has been found to inhibit interleukin-17A may significantly improve moderate-to-severe plaque psoriasis, according to new phase 2 study data recently released.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.